Operational characteristics of (11)c-choline positron emission tomography/computerized tomography for prostate cancer with biochemical recurrence after initial treatment.
about
Salvage local therapy for radiation-recurrent prostate cancer - where are we?PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data.Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial.Positron Emission Tomography in Prostate Cancer: Summary of Systematic Reviews and Meta-Analysis.Evaluation of Posttreatment Follow-Up of Patients With Prostate Cancer Relative to the American College of Radiology's Appropriateness Criteria18F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patients.Radiopharmaceuticals as probes to characterize tumour tissue.Emerging treatments for recurrent prostate cancer.Diagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizons.A urologist's perspective on prostate cancer imaging: past, present, and future.PET imaging of recurrent and metastatic prostate cancer with novel tracers.Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: A Nomogram for Predicting Extrapelvic Disease.Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancer.Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography.PET Tracers Beyond FDG in Prostate Cancer.Diffusion weighted imaging of the prostate-principles, application, and advances.Intensity-modulated salvage radiotherapy with simultaneous integrated boost for local recurrence of prostate carcinoma: a pilot study on the place of PET-choline for guiding target volume delineation.Performance characteristics and relationship of PSA value/kinetics on carbon-11 acetate PET/CT imaging in biochemical relapse of prostate cancer.Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy Meeting.[Potential of PET/MRI for diagnosis of prostate cancer].Current status of theranostics in prostate cancer.Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study.Target definition in salvage postoperative radiotherapy for prostate cancer: 18F-fluorocholine PET/CT assessment of local recurrence.The use of PET/CT in prostate cancer.Prostate cancer post-treatment follow-up and recurrence evaluation.Comparison of meta-analyses among elastosonography (ES) and positron emission tomography/computed tomography (PET/CT) imaging techniques in the application of prostate cancer diagnosis.Trigger pSA predicting recurrence from positive choline PET/CT with prostate cancer after initial treatment.
P2860
Q28065991-0DABCAC3-FF9B-41B2-B64B-607E5791E8E1Q31003607-3514CD1F-205E-420B-B1D4-8F1DC6EC1A9AQ34139498-98F1F28E-6355-46E5-833E-EC0DD6E3C535Q36418328-39B7DA4E-4D9D-46AA-A8A8-6D42F9DDEAF0Q36652042-FD1E7200-9228-4776-9B87-AA2BC589C7CFQ38098441-25D3AC03-9C39-48AB-8C5B-1CD88FB924B7Q38342458-8E20AD96-53C4-4BBA-8FFB-E5083F97CB43Q38599162-8A6F4BE9-829C-4C79-994E-CDF5C5BD2E20Q38766102-21B69A8A-6369-430E-8A3A-D87A4FBAD260Q38823661-69177F96-AB4A-4BFB-86DC-C02042626695Q38831029-99B91B9A-09B9-4C0D-B215-FED33D394D61Q38946874-ECF02DE5-7643-4A75-A977-217B696118F2Q38966705-F7DA3B3E-B5AB-4090-953E-CCB88184D0B6Q38996907-44496BFB-3628-4C1B-88DC-653546BA6060Q39003086-544A2AE2-816B-47DF-A289-90322F10AD02Q39446440-A7516C41-865A-41B9-9806-7584FFC170A3Q41787130-7CE54735-3C38-496A-92B8-4BC71293B6BEQ42230054-095BDC0C-7811-42E7-A7BF-13A4011D1C86Q43578455-6089E1D6-EDB4-47D1-9117-0E510B2032C8Q43636204-234EC6AD-DA42-4A00-9A4F-C2C93074D38AQ47241139-C1D8BC8F-0A3B-4566-B8A1-A93964D32C5FQ47857567-E4229090-F4E2-4F92-AD6F-78310C2091BCQ49565026-0BBFBB30-0028-4249-80C3-EFDD189D70F4Q49919217-3F0099C9-3CD7-42C6-B3C2-429D21DEFB64Q52982867-39A13A7D-DCCC-4F2E-87B3-D5D68796492CQ52990619-5724845F-C3B4-47FD-8313-55EDF227CAACQ55188040-B368BDBA-9909-441B-90D7-D80C17F866A8
P2860
Operational characteristics of (11)c-choline positron emission tomography/computerized tomography for prostate cancer with biochemical recurrence after initial treatment.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Operational characteristics of ...... rence after initial treatment.
@en
type
label
Operational characteristics of ...... rence after initial treatment.
@en
prefLabel
Operational characteristics of ...... rence after initial treatment.
@en
P2093
P1476
Operational characteristics of ...... rence after initial treatment.
@en
P2093
Christopher R Mitchell
Eugene D Kwon
Joseph C Hung
Laureano J Rangel
R Jeffrey Karnes
Val J Lowe
P304
P356
10.1016/J.JURO.2012.10.069
P407
P577
2012-10-30T00:00:00Z